V Founded in 1885 by James and Edward Mead

Johnson
V Largest manufacturer of health care products
in the world
V Incorporates more than 180 subsidiaries
worldwide
V Employs nearly 120,000 workers world wide.
V Currently operating in markets of more than
175 countries
V Sales of 15.1$ billion in third quarter of 2009
V rorldǯs premier consumer health company
V rorldǯs largest and most diversed medical
devices and diagnostics company
V rorldǯs 4th largest biologics company
V rorldǯs 7th largest pharmaceuticals company
V re believe our first responsibility is to the
doctors, nurses and patients, to mothers and
fathers and all others who use our products
and services. In meeting their needs
everything we do must be of high quality.
V ïighly competitive industry
V Research based and driven by new
discoveries
V Strict Rules and Regulations
V Patent Rights to protect the rights of
innovator
V Urgency b/w companies to bring in new
products
V hhe company splits its business into three
major segments:
1. Consumer Segment
2. Medical devices and diagnostic segment
3. Pharmaceutical segment
_aby care Skin care Oral care round care

romenǯs health care OhC pharmaceutical products

Includes a broad range of products distributed
to wholesalers, hospitals and retailers.
Used principally in the professional fields by
physicians, nurses, therapists, hospitals,
diagnostic laboratories and clinics.
hheseproducts include :
V Cordisǯ circulatory disease management products
V DePuyǯs orthopaedic joint reconstruction
V Spinal care and sports medicine products
V Ethiconǯs surgical care
V romenǯs health products
V Ethicon Endo-Surgeryǯs minimally invasive surgical products
V LifeScanǯs blood glucose monitoring
V Insulin delivery products
V Ortho-Clinical Diagnosticsǯ professional diagnostic products
V Vistakonǯs disposable contact lenses
Includes products in following therapeutics:
V Antifungal
V Anti-infective
V Antipsychotic
V Cardiovascular
V Contraceptive
Dermatology
V Gastrointestinal
V ïematology
V Immunology
V Neurology
V Oncology
V Pain management
V Urology
V Virology
V Decentralized in nature
V _ased on credos and values
V In initial times-heaming up with smaller
medical suppliers in partnerships instead of
acquiring them outright.
V Current-hhree new units to focus on
Convergence and new opportunities:
1. Surgical care group-focus on advance
technoligies
2. Comprehensive care group-worldǯs most
chronic and pervasive conditions
V Strong brand value
V _rand loyalty
V Low threats of new entrants because of high
investment .
V Yet to explore Mexican and South American
markets
V Glaxo Smith kline
V Eli lilly
V Astra Zeneca
V Pfizer
V Novartis
V P&G
V Sanofi-Aventis Group